Tibboel Helen, De Houwer Jan, Van Bockstaele Bram
Department of Experimental-Clinical and Health Psychology, Ghent University, Ghent, Belgium.
Department of Experimental-Clinical and Health Psychology, Ghent University, Ghent, Belgium.
Neurosci Biobehav Rev. 2015 Oct;57:350-64. doi: 10.1016/j.neubiorev.2015.09.015. Epub 2015 Sep 30.
Incentive Sensitization Theory (IST; e.g., Robinson and Berridge, 1993. Brain Res. Rev., 18, 291; Robinson and Berridge, 2003 Trends Neurosci., 26, 507) suggests that a common dopamine system that deals with incentive salience attribution is affected by different types of drugs. Repeated drug use will sensitize this neural system, which means that drugs increasingly trigger the experience of incentive salience or "wanting". Importantly, Robinson and Berridge stress that there is a dissociation between drug "wanting" (the unconscious attribution of incentive salience) and drug "liking" (the unconscious hedonic experience when one consumes drugs). Whereas the former plays an essential role in the development and maintenance of drug addiction, the latter does not. Although this model was based mainly on research with non-human animals, more recently the dissociation between "wanting" and "liking" has been examined in humans as well. A widely used and promising means of studying these processes are behavioral implicit measures such as the Implicit Association Test (IAT), the Approach-Avoidance Task (AAT), different types of Stimulus-Response Compatibility (SRC) tasks, and Affective Simon Tasks (AST). IST makes the clear prediction that (1) there should be a positive correlation between indices of "wanting" (e.g., drug consumption) and implicit "wanting" scores. Similarly, there should be a positive correlation between indices of "liking" (e.g., various expressions of subjective pleasure) and implicit "liking" scores; (2) there should be higher "wanting" scores in substance abusers or frequent substance users compared to non-users or infrequent users, and there should be no differences in "liking" between these groups (or even less "liking" in frequent substance users); (3) manipulations of "wanting" should affect implicit "wanting" scores whereas manipulations of "liking" should affect implicit "liking" scores. However, studies that tested these hypotheses did not produce equivocal results. To shed light on these discrepancies, we first discuss the different definitions of "wanting" and "liking" and the different tests that have been used to assess these processes. Then, we discuss whether it is reasonable to assume that these tests are valid measures of "wanting" and "liking" and we review correlational, quasi-experimental, and experimental studies that inform us about this issue. Finally, we discuss the future potential of implicit measures in research on IST and make several recommendations to improve both theory and methodology.
动机敏感化理论(IST;例如,Robinson和Berridge,1993年。《脑研究回顾》,18卷,291页;Robinson和Berridge,2003年。《神经科学趋势》,26卷,507页)表明,一个负责动机显著性归因的共同多巴胺系统会受到不同类型药物的影响。反复使用药物会使这个神经系统敏感化,这意味着药物越来越多地引发动机显著性体验或“渴望”。重要的是,Robinson和Berridge强调,药物“渴望”(动机显著性的无意识归因)和药物“喜好”(服用药物时的无意识享乐体验)之间存在分离。虽然前者在药物成瘾的发展和维持中起着至关重要的作用,但后者并非如此。尽管这个模型主要基于对非人类动物的研究,但最近“渴望”和“喜好”之间的分离也在人类身上得到了研究。研究这些过程的一种广泛使用且有前景的方法是行为内隐测量,如内隐联想测验(IAT)、趋近-回避任务(AAT)、不同类型的刺激-反应相容性(SRC)任务和情感西蒙任务(AST)。IST明确预测:(1)“渴望”指标(如药物消费)与内隐“渴望”分数之间应存在正相关。同样,“喜好”指标(如主观愉悦的各种表现)与内隐“喜好”分数之间也应存在正相关;(2)与非使用者或不常使用者相比,药物滥用者或频繁使用药物者的“渴望”分数应该更高,并且这些组之间的“喜好”没有差异(或者频繁使用药物者的“喜好”甚至更低);(3)对“渴望”的操纵应该影响内隐“渴望”分数,而对“喜好”的操纵应该影响内隐“喜好”分数。然而,检验这些假设的研究并没有得出明确的结果。为了阐明这些差异,我们首先讨论“渴望”和“喜好”的不同定义以及用于评估这些过程的不同测试。然后,我们讨论假设这些测试是“渴望”和“喜好”的有效测量方法是否合理,并回顾相关研究、准实验研究和实验研究,这些研究为我们提供了关于这个问题的信息。最后,我们讨论内隐测量在IST研究中的未来潜力,并提出一些改进理论和方法的建议。